Apolipoprotein E:: a major piece in the Alzheimer's disease puzzle

被引:91
作者
Cedazo-Mínguez, A [1 ]
Cowburn, RF [1 ]
机构
[1] Karolinska Inst, NEUROTEC, Div Expt Geriat, NOVUM KFC, S-14186 Huddinge, Sweden
关键词
Alzheimer's disease; apolipoprotein E; amyloid; cell signalling; oxidative stress; synaptic plasticity;
D O I
10.1111/j.1582-4934.2001.tb00159.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Alzheimer's disease (AD) is a complex neurodegenerative disorder with multiple etiologies. The presence of the E4 isoform of apolipoprotein E (apoE) has been shown to increase the risk and to decrease the age of onset for AD and is the major susceptibility factor known for the disease. ApoE4 has been shown to intensify all the biochemical disturbances characteristic of AD, including beta amyloid (AP) deposition, tangle formation, neuronal cell death, oxidative stress, synaptic plasticity and dysfunctions of lipid homeostasis and cholinergic signalling. In contrast, other apoE isoforms are protective. Here we review and discuss these major hypotheses of the apoE4-AD association.
引用
收藏
页码:254 / 266
页数:13
相关论文
共 68 条
  • [1] Disturbance of neuronal plasticity is a critical pathogenetic event in Alzheimer's disease
    Arendt, T
    [J]. INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2001, 19 (03) : 231 - 245
  • [2] Apolipoprotein E is essential for amyloid deposition in the APPV717F transgenic mouse model of Alzheimer's disease
    Bales, KR
    Verina, T
    Cummins, DJ
    Du, YS
    Dodel, TC
    Saura, J
    Fishman, CE
    DeLong, CA
    Piccardo, P
    Petegnief, V
    Ghetti, B
    Paul, SM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (26) : 15233 - 15238
  • [3] Altered apolipoprotein E secretion in cytokine treated human astrocyte cultures
    Baskin, F
    Smith, GM
    Fosmire, JA
    Rosenberg, RN
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1997, 148 (01) : 15 - 18
  • [4] The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease
    Beffert, U
    Danik, M
    Krzywkowski, P
    Ramassamy, C
    Berrada, F
    Poirier, J
    [J]. BRAIN RESEARCH REVIEWS, 1998, 27 (02) : 119 - 142
  • [5] Functional interaction of beta-catenin with the transcription factor LEF-1
    Behrens, J
    vonKries, JP
    Kuhl, M
    Bruhn, L
    Wedlich, D
    Grosschedl, R
    Birchmeier, W
    [J]. NATURE, 1996, 382 (6592) : 638 - 642
  • [6] No evidence for cholinergic problems in apolipoprotein E knockout and apolipoprotein E4 transgenic mice
    Bronfman, FC
    Tesseur, I
    Hofker, MH
    Havekens, LM
    Van Leuven, F
    [J]. NEUROSCIENCE, 2000, 97 (03) : 411 - 418
  • [7] Tau protein isoforms, phosphorylation and role in neurodegenerative disorders
    Buée, L
    Bussière, T
    Buée-Scherrer, V
    Delacourte, A
    Hof, PR
    [J]. BRAIN RESEARCH REVIEWS, 2000, 33 (01) : 95 - 130
  • [8] A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia
    Bullido, MJ
    Artiga, MJ
    Recuero, M
    Sastre, I
    Garcia, MA
    Aldudo, J
    Lendon, C
    Han, SW
    Morris, JC
    Frank, A
    Vázquez, J
    Goate, A
    Valdivieso, F
    [J]. NATURE GENETICS, 1998, 18 (01) : 69 - 71
  • [9] Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neurodegenerative disease
    Buttini, M
    Akeefe, H
    Lin, C
    Mahley, RW
    Pitas, RE
    Wyss-Coray, T
    Mucke, L
    [J]. NEUROSCIENCE, 2000, 97 (02) : 207 - 210
  • [10] Buttini M, 1999, J NEUROSCI, V19, P4867